Abstract
Despite numerous synthetic efforts and extensive SAR studies on paclitaxel analogs, little work has been devoted to derive SAR of the C-1 hydroxy group. Up to now, 1-deoxypaclitaxel has only been reported to be isolated from the Chinese yew, Taxus mairei (Taxaceae). However, the isolation from natural sources does not solve the availability problem due to the reported low yield of isolation. Also, only several analogues of this type have been reported. Thus, there is an urgent need for exploration of new synthetic methods on this structurally intriguing molecule and further SAR studies. In present work, we report the initial expedient semi-synthesis of 1-deoxypaclitaxel and its novel analogues with structural variations at C7 and C10 from 1-deoxybaccatin VI, as well as their cytotoxic activities against A 549 cell line.
Keywords: Analogues, Bioactivity, 1-Deoxybaccatin VI, 1-Deoxypaclitaxel, Paclitaxel, Synthesis, Taxaceae, Taxus brevifolia, hydroxyl group, carrcinoma
Medicinal Chemistry
Title:Semi-synthesis of 1-Deoxypaclitaxel and its Analogues from 1-Deoxybaccatin VI
Volume: 8 Issue: 5
Author(s): Dan-Hui Jin, Yong-Mei Cui and Hai-Xia Lin
Affiliation:
Keywords: Analogues, Bioactivity, 1-Deoxybaccatin VI, 1-Deoxypaclitaxel, Paclitaxel, Synthesis, Taxaceae, Taxus brevifolia, hydroxyl group, carrcinoma
Abstract: Despite numerous synthetic efforts and extensive SAR studies on paclitaxel analogs, little work has been devoted to derive SAR of the C-1 hydroxy group. Up to now, 1-deoxypaclitaxel has only been reported to be isolated from the Chinese yew, Taxus mairei (Taxaceae). However, the isolation from natural sources does not solve the availability problem due to the reported low yield of isolation. Also, only several analogues of this type have been reported. Thus, there is an urgent need for exploration of new synthetic methods on this structurally intriguing molecule and further SAR studies. In present work, we report the initial expedient semi-synthesis of 1-deoxypaclitaxel and its novel analogues with structural variations at C7 and C10 from 1-deoxybaccatin VI, as well as their cytotoxic activities against A 549 cell line.
Export Options
About this article
Cite this article as:
Jin Dan-Hui, Cui Yong-Mei and Lin Hai-Xia, Semi-synthesis of 1-Deoxypaclitaxel and its Analogues from 1-Deoxybaccatin VI, Medicinal Chemistry 2012; 8 (5) . https://dx.doi.org/10.2174/157340612802084379
DOI https://dx.doi.org/10.2174/157340612802084379 |
Print ISSN 1573-4064 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6638 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Biochemical, Biomedical and Metabolic Aspects of Imidazole-Containing Dipeptides with the Inherent Complexity to Neurodegenerative Diseases and Various States of Mental Well-Being: A Challenging Correction and Neurotherapeutic Pharmaceutical Biotechnology for Treating Cognitive Deficits, Depression and Intellectual Disabilities
Current Pharmaceutical Biotechnology <i>Uncaria rhynchophylla</i> and its Major Constituents on Central Nervous System: A Review on Their Pharmacological Actions
Current Vascular Pharmacology COVID-19 Pandemic – Are We Heading From Health Crisis Towards An Unprecedented Nutrition Crisis?
Current Topics in Medicinal Chemistry Traumatic Stress Reactions in Parents in Pediatric Intensive Care: A Review
Current Psychiatry Reviews Molecular Foundations for Personalized Therapy in Prostate Cancer
Current Drug Targets Cilostazol in the Management of Atherosclerosis
Current Vascular Pharmacology Mathematical Methods to Analysis of Topology, Functional Variability and Evolution of Metabolic Systems Based on Different Decomposition Concepts
Current Drug Metabolism Status of Flavonols as P-Glycoprotein Inhibitors in Cancer Chemotherapy
Current Cancer Therapy Reviews Effects of Estrogen in the Brain: Is it a Neuroprotective Agent in Alzheimers Disease?
Current Aging Science Sepsis: Links between Pathogen Sensing and Organ Damage
Current Pharmaceutical Design The Relationship among Splenomegaly, Lung Involvement Patterns, and Severity Score in COVID-19 Pneumonia
Current Medical Imaging Design, Synthesis, Antioxidant and Anticancer Activity of New Coumarin Derivatives Linked with Thiazole, Isoxazole or Pyrazole Moiety
Letters in Drug Design & Discovery Glycyrrhizin as a Potential Treatment for the Novel Coronavirus (COVID-19)
Mini-Reviews in Medicinal Chemistry Pidotimod and Immunological Activation in Individuals Infected with HIV
Current HIV Research A Refined Framework for Precision and Translational Proteomics in Clinical Research
Current Proteomics New Synthetic Antibiotics for the Treatment of Enterococcus and Campylobacter Infection
Current Topics in Medicinal Chemistry Studies on Chemistry, Spectroscopy and Antioxidant Activities of Chromium(III)-Hydrazide Complexes
Medicinal Chemistry Peptides and Small Molecules Targeting the Plasminogen Activation System: Towards Prophylactic Anti-Metastasis Drugs for Breast Cancer
Recent Patents on Anti-Cancer Drug Discovery QSAR in the Pharmaceutical Research Setting: QSAR Models for Broad, Large Problems
Current Topics in Medicinal Chemistry Complications and Outcome of H1N1 Influenza in a Tertiary Care Hospital in South India A Retrospective Study
Current Respiratory Medicine Reviews